Navigation Links
Novation Applauds New FDA Guidance Documents on Biosimilars
Date:2/15/2012

IRVING, Texas, Feb. 15, 2012 /PRNewswire/ -- The publication of three guidance documents by the Food and Drug Administration represents a significant milestone in the biosimilar development process and provides the infrastructure by which pharmaceutical manufacturers can seek approval for lower cost, clinically comparable alternatives to some of the most commonly utilized biologic agents purchased by health care organizations.     

Novation, the health care industry's leading supply contracting company for the members and affiliates of VHA Inc, UHC and Provista, has been actively monitoring the development process for biosimilars, improving its understanding of how biosimilars have progressed in Europe and identifying the keys issues members will have to address when considering how to use biosimilars.    

In recent years, an increasing amount of hospital pharmaceutical expense is being devoted to the acquisition of high cost, large molecule biologics, which historically have not been subject to "generic" competition because they are complex to manufacture and are derived from living organisms.  Biosimilars, or drugs that clinical studies deem "highly similar" to these large molecule biologics, will provide effective, safe, and cost-efficient alternatives to expensive, current biologic drugs.  

Based upon the experience in the European biosimilars market, these "highly similar" versions of reference biologics could result in price decreases of 20% to 30%.  "However, adoption of biosimilars will be a more complex process and will require greater physician involvement in contrast to what traditionally happens with small molecule generics," said Steven Lucio, director of pharmacy clinical solutions for Novation.  "Health care organizations will have to devote more resources to the evaluation of these products. Therefore, it is critically important for Novation to provide the tools and resources needed to conduct this evaluation and educate prescribers and other clinicians." 

Novation offers multiple clinical resources to the members it serves including the Drug Monograph Service and the biannual Drug Price Forecast.  Both of these tools will be expanded to reference the availability of biosimilars. Novation recently initiated the process of educating its member organizations on biosimilars with the publication of its white paper titled, "Preparing for Biosimilars." To view this white paper, please view: https://www.novationco.com/pressroom/industry_info/Biosimilars_White_Paper_201111.pdf.   

 

About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase more than $40 billion in 2011. Novation recently earned the coveted Ethics Inside® Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care group purchasing organization to earn this distinction.

 


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Year
2. Innovation Day 2012: a Time To Inform and Inspire
3. BioParadox Announces Partnership with Fogarty Institute for Innovation
4. Celebrity Chef Danny Boome Announces Launch of Arthriving.com, A New Online Resource Featuring Smart Solutions And Product Innovations For People With Arthritis
5. DLP® LightCrafter™ From Texas Instruments: Enabling Big Innovations In Light Steering From A Compact, Ready-To-Use Module
6. Utilizing Marketing Innovations to Engage with Customer Groups that are Key to the Pharmaceutical Industry
7. Innovations in Wound Care Devices and Dressings
8. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
9. First Ever InnoPack Event Has Strong Turn Out and a Focus on Innovation
10. Austen BioInnovation Institute and Lubrizol Announce New Strategic Innovation Partnership
11. Mindray Signs Agreement With Novation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology:
(Date:4/28/2016)... WASHINGTON, D.C., (PRWEB) , ... April 28, 2016 ... ... health systems, and the Campaign for Tobacco-Free Kids, a leading force in the ... to promote federal, state and local policies that can help reduce tobacco use. ...
(Date:4/28/2016)... NJ (PRWEB) , ... April 28, 2016 , ... ... BCBNSNJ), which is has been collaborating with doctors and hospitals to make transformative ... join the world’s leading cell therapy minds this week in discussing breakthroughs in ...
(Date:4/28/2016)... ... ... Amada Senior Care, premier provider of non-medical in-home care and assisted living ... West location. Prior to entering the senior care industry, Amada franchise partner Rick Stockton ... Antonio West will take place on Friday, April 29th. , Rick said ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the development of miniature microphones and headsets announced today that the US Patent ... of integrating in-earphones into a structure. This innovative design creates a lightweight and ...
(Date:4/28/2016)... , ... April 28, 2016 , ... Metabolic Nutrition ... GlycoLoad at this week’s 2016 Europa Games Get Fit and Sports Expo ... alike, the Europa Orlando Expo coming up April 29-30, was selected as the perfect ...
Breaking Medicine News(10 mins):